The debate about who should have access to genetic test results has been argued for decades. There are many factors to consider, including: individual rights, the rights of family members, medical liability, insurance issues, and the betterment of scientific research....
It is well-known that women who carry a mutation in BRCA1 or BRCA2 are at high risk to develop breast cancer (50-85% lifetime risk) and ovarian cancer (15-60% lifetime risk). Because the screening options for ovarian cancer (transvaginal ultrasound, the blood test...
Earlier this month, singer/songwriter Melissa Etheridge appeared on the Dr. Oz show to discuss her 10-year breast cancer survivorship, her BRCA+ status, and her views on cancer development. Etheridge reiterated her views on prophylactic surgery for BRCA carriers,...